請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41297
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林仁混 | |
dc.contributor.author | Kuo-Hui Lin | en |
dc.contributor.author | 林國輝 | zh_TW |
dc.date.accessioned | 2021-06-15T00:15:25Z | - |
dc.date.available | 2009-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-06-17 | |
dc.identifier.citation | 1.Kwon HS, P.J., Kim DH, Kim YH, Park JH, Shin HK, Kim JK.,
Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice., in Journal of Molecular Medicine, 30 September 2008. p. 1287–1295. 2.C., N., Points of control in inflammation. Nature, 2002 Dec 19-26. 420 (6917): p. 846-52. 3.CN., S., A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biology, 2004. 122: p. 305–321. 4.Coussens LM, W.Z., Inflammation and cancer. Nature, 19/26 DECEMBER 2002. 40: p. 860-867. 5.KJ., T., The inflammatory reflex. Nature, 2002 Dec 19-26. (6917): p. 853-9. 6.T., W.-C., Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Medicine 7 September 2006. 12: p. 1005-1015 7.Owens T, W.H., Antel J., Genetic models for CNS inflammation. Nature Medicine 2001. 7: p. 161 - 166. 8.GS., F., Evolving concepts of rheumatoid arthritis. Nature, 2003 May 15. 423(6937): p. 356-61. 9.Liew FY, M.I., A fork in the pathway to inflammation and arthritis. Nature Medicine, 2005 Jun. 11(6): p. 601-2. 10.Mathis D, V.L., Benoist C., beta-Cell death during progression to diabetes. Nature, 13 December 2001. 414(6865): p. 792-798. 11.Bensinger SJ, T.P., Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature, 2008 Jul 24. 454(7203): p. 470-7. 12.P., L., Inflammation in atherosclerosis. Nature, 2002 Dec 19-26. 420(6917): p. 868-74. 13.Mantovani A, A.P., Sica A, Balkwill F., Cancer-related inflammation. Nature, 2008 Jul 24. 454(7203): p. 436-44. 14.J., C., The immunopathogenesis of sepsis. Nature, 2002 Dec 19-26. 420(6917): p. 885-91. 15.Kundu JK, S.Y., Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutation Research, 2005. 591: p. 123–146. 16.Kirwan J, P.L., Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Current Opinion in Rheumatology, 2007. 19: p. 233–237. 17.BE., S., Inflammatory bowel disease: past, present, and future. Jornul of Gastroenterology, 2007 Jan. 42(1): p.16-25. 18.Ciccone A, B.S., Brusaferri F, Galea I, Protti A, Spreafico C., Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database of Systematic Reviews, 2008 Jan 23. 1. 19.L., B., Evaluating combination therapies for asthma: pros, cons, and comparative benefits. Therapeutic Advances in Respiratory Disease, 2008 Jun. 2(3): p. 149-61. 20.Fiorucci S, S.L., Distrutti E., NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: What lies beyond the horizon. Digestive and Liver Disease, 2007 Dec.39(12): p. 1043-51. 21.Swierkot J, S.J., Methotrexate in rheumatoid arthritis. Pharmacological Report, 2006 Jul-Aug. 58(4): p. 473-92. 22.Chen Y, Y.L., Lee TJ., Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-KB activation. Biochemical Pharmacology, 2001. 59: p. 1445–1457. 23.Afanas'eva IB, O.E., Mikhal'chik EV, Ibragimova GA, Korkina LG., Enhancement of antioxidant and anti-inflammatory activities of biflavonoid rutin by complexation with transition metals. Biochemical Pharmacology, 2001. 61: p. 677–684. 24.Chen YC, S.S., Lee WR, Hou WC, Yang LL, Lee TJ., Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. Journal of Cellular Biochemistry, 2001. 82: p. 537–548. 25.Shen SC, L.W., Lin HY, Huang HC, Ko CH, Yang LL, Chen YC., In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production. European Journal of Pharmacology, 2002. 446: p. 187–194. 26.Sultana S, P.S., Iqbal M, Athar M., Crude extracts of hepatoprotective plants,Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. Journal of Ethnopharmacology, 1995. 45: p. 189-192. 27.Lin HM, T.H., Wang CJ, Lin JJ, Lo CW, Chou FP., Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chemico-Biological Interactions, 2008 171 (3): p. 283-293 28.Jainu M, D.C., Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: Possible mechanism for the inhibition of acid formation. Journal of Ethnopharmacology, 2006. 104: p. 156–163. 29.Prashanth Kumar V, S.S., Kumar MM, Sridhara BY., Cytoprotective role of Solanum nigrum against gentamycin induced kidney cell (vero cells) damage in vitro. Fitoterapia, 2001. 72: p. 481–486. 30.Li J, L.Q., Feng T, Li K., Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells. Fitoterapia, 2008. 79: p. 548–556. 31.Lee SJ, L.K., 150 kDa glycoprotein isolated from Solanum nigrum Linne stimulates caspase-3 activation and reduces inducible nitric oxide production in HCT-116 cells. Toxicology in Vitro, 2006. 20: p. 1088–1097. 32.Hsieh CC, F.H., Lina WC., Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice. Journal of Ethnopharmacology, 2008. 119: p. 117–121. 33.Lee SJ, K.J., Lim K, Lim KT., 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacological Research, 2005. 51: p. 399–408. 34.An L, T.J., Liu XM, Gao NN., [Review about mechanisms of anti-cancer of Solanum nigrum.]. Zhongguo Zhong. Yao Za Zhi. , 2006. 31 (15 ): p. 1225-6, 1260 35.Saijo R, M.K., Nohara T, Tomimatsu T, Sato A, Matsuoka K. , [Studies on the constituents of Solanum plants. II. On the constituents of the immature berries of Solanum nigrum L. (author's transl).]. Yakugaku Zasshi 1982 102 (3): p. 300-305 36.RP., T., A case of poisoning by Solanum nigrum. Irish Journal of Medical Science, 1953 6 (326 ): p. 77-80 37.Son YO, K.J., Lim JC, Chung Y, Chung GH, Lee JC., Ripe fruit of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells. Food and Chemical Toxicology, 2003 41 (10 ): p. 1421-1428 38.Lin HM, T.H., Wang CJ, Chyau CC, Liao KK, Peng PL, Chou FP.,Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. Journal of Agricultural and Food Chemistry , 2007 55 (9 ): p.3620-3628 39.Kawai T, A.S., Signaling to NF-kB by Toll-like receptors. TRENDS in Molecular Medicine, 2007. 13(11): p. 460-469. 40.Akira S, U.S., Takeuchi O., Pathogen Recognition and Innate Immunity. Cell,February 24, 2006. 124: p. 783–801. 41.LA., O.N., How Toll-like receptors signal: what we know and what we don’t know. Current Opinion in Immunology, 2006. 18: p. 3–9. 42.Hayden MS, G.S., Shared Principles in NF-κB Signaling. Cell, February 8, 2008. 132: p. 344-362. 43.Chen LF, G.W., Shaping the nuclear action of NF-κB. Molecular Cell Biology, MAY 2004. 5: p. 392-401. 44.Gloire G, L.-P.S., Piette J., NF-kB activation by reactive oxygen species:Fifteen years later. Biochemical pharmacology, 2006. 72: p. 1493 – 1505. 45.M., K., How NF-κB is activated: the role of the I-κB kinase (IKK) complex. Oncogene, 1999. 18: p. 6867–74. 46.YJ., S., Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 2003. 3: p. 768–80. 47.M., K., Mitogen-activated protein kinase cascades as regulators of stress responses. Annal New York Academy of Science, 1998. 851: p. 139–146. 48.Owuor ED, K.A., Antioxidants an oxidants regulated signal transduction pathways. Biochemical Pharmacology, 2002. 64: p. 765–770. 49.Chang L, K.M., Mammalian MAP kinase signaling cascades. Nature, 2001. 410: p. 37–40. 50.Schroeter H, B.C., Spencer JP, Williams RJ, Cadenas E, Rice-Evans C., MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiology of Aging, 2002. 23: p. 861–880. 51.Hambleton J, W.S., Lem L, DeFranco AL., Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proceedings of the National Academy of Sciences, 1996 April 2. 93(7): p. 2774–2778. 52.Kyriakis JM, A.J., Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews, 2001. 81: p. 807–869. 53.Gupta S, B.T., Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, Davis RJ., Selective interaction of JNK protein kinase isoforms with transcription factors. The EMBO Journal, 1996. 15: p. 2760–2770. 54.Rincón M, F.R., AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. The EMBO Journal, 1994. 13: p. 4370. 55.Roux PP, B.J., ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions. Microbiology and Molecular Biology Reviews, June 2004. 68(2): p. 320–344. 56.Han J, L.J., Bibbs L, Ulevitch RJ., A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science, 1994. 265: p. 808- 11. 57.Ono K, H.J., The p38 signal transduction pathway: activation and function. Cell Signalling, 2000. 12: p. 1–13. 58.Forstermann, U., Li, H., Schwarz, P.M., Kleinert, H., NO synthesis and NOS regulation. Kluwer Academic, Dordrecht., 2003: p. 119–154. 59.C., B., Nitric oxide and the immune response. Nature Immunology, 2001. 2: p. 907– 916. 60.Kröncke KD, F.K., Kolb-Bachofen V., Inducible nitric oxide synthase in human diseases. Clinical & Experimental Immunology, 1998. 113: p.147–156. 61.Suh N, H.T., Finlay HJ, Barchowsky A, Williams C, Benoit NE, Xie QW, Nathan C, Gribble GW, Sporn MB., Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Research, 1998. 58: p. 717–723. 62.O'Neill GP, F.-H.A., Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Letters, 1993. 330: p. 156–160. 63.Vane JR, B.Y., Botting RM., Cyclooxygenases 1 and 2. Annual Review of Pharmacology Toxicology, 1998. 38: p. 97–120. 64.Williams CS, D.R., Prostaglandin endoperoxide synthase: why two isoforms? American Journal of Physiology, 1996. 270: p. G393–G400. 65.KK., W., Cyclooxygenase-2 induction: molecular mechanism and pathophysiologic roles. Journal of Laboratory and Clinical Medicine, 1996. 128: p. 242–245. 66.Marnett LJ, R.S., Goodwin DC, Kalgutkar AS, Lanzo CA., Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. Journal of Biological Chemistry, 1999. 274: p. 22903–22906. 67.Bartsch H, N.J., Oxidative stress and lipid peroxidation-derived DNAlesions in inflammation driven carcinogenesis. Cancer Detection and Prevention Journal, 2004. 28: p. 385–91. 68.GM., H., Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutation Research, 2005. 571: p. 107–20. 69.YJ., S., Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food and Chemical Toxicology, 2002. 40: p. 1091–7. 70.Paravicini TM, T.R., NADPH Oxidases, Reactive Oxygen Species, and Hypertension. Diabetes Care, February 2008. 31(2): p. s170-s180. 71.Moncada S, P.R., Higgs EA., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991. 43: p. 109-142. 72.Chen T, S.G., Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis. Molecular Carcinogenesis, 2004. 40: p. 232–240. 73.Jaiswal M, L.N., Gores GJ., Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2001. 281: p. G626–G634. 74.Hussain SP, H.C., Inflammation and cancer: an ancient link with novel potentials. International Journal of Cancer, 2007. 121: p. 2373–2380. 75.Maeda H, A.T., Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Moscow), 1998. 63: p. 854–865. 76.Thanos D, M.T., NF-kB: a lesson in family values. Cell, 1995. 80: p. 529-32. 77.Fujihara M, I.N., Pace JL, Watanabe Y, Russell SW, Suzuki T., Role of interferon-b in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. Journal of Biological Chemistry, 1994. 269: p. 12773. 78.Thanos D, M.T., NF-kB: a lesson in family values. Cell, 1995. 80: p. 529-32. 79.Fujihara M, I.N., Pace JL, Watanabe Y, Russell SW, Suzuki T., Role of interferon-b in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. Journal of Biological Chemistry, 1994. 269: p. 12773. 80.V., C., Signaling pathways controlling the production of inflammatory mediators in response to crystalline silica exposure: role of reactive oxygen ⁄ nitrogen species. Free Radical Biology & Medicine, 2004. 37: p. 916–925. 81.Marks-Konczalik J, C.S., Moss J., Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappa B-binding sites. Journal of Biological Chemistry, 1998. 273: p. 22201–22208. 82.Nordberg J, A.E., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology & Medicine, 2001. 31: p. 1287–1312. 83.S., C., Role of nitric oxide and reactive oxygen species in arthritis. Current Pharmaceutical Design, 2006. 12: p. 3551–3570. 84.Moncada S, P.R., Higgs EA., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991. 43: p. 109-142. 85.Singh VK, M.S., Narayan P, Pandey CM, Agarwal SS., Modulation of autoimmune diseases by nitric oxide. Immunologic Research, 2000. 22: p. 1–19. 86.Meade EA, S.W., DeWitt DL., Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry, 1993. 268: p. 6610-6614. 87.Barnes PJ, K.M., Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine, 1997. 36: p. 1066–1071. 88.Lin YL, L.J., (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kB. Molecular Pharmacology, 1997. 52: p. 465–472. 89.Swantek JL, C.M., Geppert TD., Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/MAPK. Molecular and Cellular Biology, 1997. 17: p. 6274–6282. 90.van der Bruggen T, N.S., van Raaij E, Verhoef J, van Asbeck BS., Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1–MEK2/ERK1–ERK2 pathway. Infection and Immunity, 1999. 67: p. 3824–3829. 91.Andersson K, S.R., Signaling to translational activation of tumour necrosis factor-a expression in human THP-1 cells. Cytokine, 2000. 12: p. 1784–1787. 92.Xagorari A, R.C., Papapetropoulos A., Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. British Journal of Pharmacology, 2002. 136: p. 1058–1064. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41297 | - |
dc.description.abstract | Solanum nigrum Linn (SNL),中文名稱為龍葵,他是屬於茄科家族的一位成員,在野外常常可以很容易地見到他的蹤跡。在傳統上,龍葵常常被用來當作中藥來使用,並且主要是用來治療發炎與癌症等疾病。根據統計,有百分之二十五左右的癌症被認為與慢性感染及發炎有關。在文獻中普遍認為由慢性發炎組織中的巨噬細胞所產生出來的活性氧分子(Reactive Oxygen Species,ROS)及活性氮分子
(Reactive Nitrogen Species,RNS)會對細胞內的DNA造成損傷,進而造成癌症的產生。而在這過程中,一些與製造活性氧分子及二十碳烯酸(Eicosanoid)相關的酵素[e.g. 第二型煙醯胺腺嘌呤二核苷酸磷酸氧化酶(NADPH Oxidase-2,NOX-2),黃嘌呤氧化酶(Xanthine Oxidase,XO),誘導型一氧化氮合成酶(inducible Nitric Oxide Synthase,iNOS),第二型環氧合成酶(Cyclooxygenase-2,COX-2)]其調節上的異常已經被證實對此過程有很重要的影響。在巨噬細胞中,與這些酵素有關的訊息傳導途徑主要包含核轉錄因子-κB(Nuclear Factor-κB,NF-κB)、轉錄激活蛋白-1 (Activator Protein-1,AP-1)、促分裂素原活化蛋白激酶(Mitogen-Activated Protein Kinase,MAPK)等途徑。因此,透過研究一些具有抗發炎潛力的物質可能對在發炎及癌化等方面上的化學預防會有很重要的幫助。 為了探討龍葵水萃物其所具有的抗氧化及抗發炎效應,我們藉由XO活性測定法(Xanthine Oxidase activity assay),發現到龍葵的葉子及綠果實水萃物部分對於黃嘌呤氧化酶的活性具有比較顯著的抑制能力,然而在莖的水萃物部分就沒有這樣的結果。另外也有使用亞硝酸鹽測定(nitrite assay)來檢測龍葵對於脂多醣 (Lipopolysaccharide,LPS)激活處理下的鼠類巨噬細胞RAW 264.7其一氧化氮釋放能力的影響。我們發現到僅有龍葵的葉子及綠果實水萃物具有抑制一氧化氮釋放的能力。除此之外我們還發現到僅有龍葵葉子的水萃物可以抑制脂多醣激活處理下的RAW 264.7細胞其活性氮分子產生的情形。從這裡我們可以推測龍葵葉子的水萃物可能就是藉由降低鼠類巨噬細胞RAW 264.7之一氧化氮、活性氮分子的生成並且抑制黃嘌呤氧化酶的活性來達到抗發炎的作用。另外還有使用西方墨點法(western blot)去分析龍葵葉子水萃物對於細胞內的發炎訊息傳導途徑影響情形。這邊的實驗結果顯示出龍葵葉子水萃物不但可以抑制細胞內的p38/JNK MAPK活性,同時也可以去降低NF-κB (p65)/AP-1 (phospho c-jun)的核移位(nucleus translocation)程度。在反轉錄聚合酶鏈鎖反應(RT-PCR)實驗中,我們還發現到龍葵葉子水萃物可以抑制脂多醣激活處理下的RAW 264.7細胞其iNOS mRNA的表現。 | zh_TW |
dc.description.abstract | Solanum nigrum Linn (SNL), a member of the Solanaceae family , is a common herb that grows wildly and abundantly in open fields .Traditionally, it has been used in chinese medicine for curing inflammatory disease and various kinds of cancers. Approximately, 25 % of all cancers are somehow associated with chronic infection and inflammation. Chronic inflammation is considered as a possible mechanism in
initiating tumorigenesis, resulting from the generation of ROS (Reactive Oxygen Species)/RNS (Reactive Nitrogen Species) by macrophages in the inflamed tissue and resulted in DNA damage. Chronic dysregulated activation of some cellular ROS/Eicosanoid generating enzymes, NOX-2 (NADPH Oxidase-2), XO (Xanthine Oxidase),iNOS (inducible Nitric Oxide Synthase) and COX-2 (Cyclooxygenase-2), have been shown to play pivotal roles during this process. The signal transduction pathways related to these enzymes in macrophages mainly including NF-κB/AP-1/MAPK pathway. Thus, to study the mechanism of the potential agents with anti-inflammatory activities might be important in the effects of chemoprevention of chronic inflammation and carcinogenesis. The main aim of this study is to evaluate the anti-oxidant and anti-inflammatory effects about Solanum nigrum Linn water extracts (SNE). Using the xanthine oxidase activity assay, we found that the stem water extracts of SNL didn't inhibit xanthine oxidase activity, but only the leaf and green fruit water extracts of SNL demonstrate the inhibitory activity. We also used the nitrite assay to investigate the inhibition ability of SNL on the nitrite released in culture medium of LPS-stimulated RAW 264.7 cells. We found that only the leaf and green fruit water extracts of SNL effectively inhibited the nitrite excretion. Additionally, the leaf water extracts of SNL effectively inhibited the ROS production in LPS-stimulated RAW 264.7 cells, but the stem and fruit water extracts of SNL didn’t. These results suggested that the leaf water extracts of SNL might exert the anti-inflammatory actions by suppressing NO and ROS production and xanthine oxidase activity. Moreover, we used western blot to investigate the inhibition ability of the leaf water extracts on the cellular inflammatory signal transduction pathway . The data demonstrated that the leaf water extracts greatly inhibited the p38/JNK MAPK activity , and also had the ability to decrease the NF-κB (p65)/AP-1 (phospho c-jun) nuclear translocation level. Then, we used RT-PCR to assay the iNOS mRNA expression, indicating that the leaf water extracts could inhibit iNOS mRNA expression dose-dependently. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T00:15:25Z (GMT). No. of bitstreams: 1 ntu-98-R96442015-1.pdf: 2515322 bytes, checksum: 519afed33bdd348df8a0d36d7cfa56ef (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 中文摘要:2
Abstract:4 Introduction:6 Materials and Methods:22 Results:28 Discussion:35 Reference Lists:41 Figures:55 | |
dc.language.iso | en | |
dc.title | 龍葵葉子水萃物作用於鼠類巨噬細胞株RAW 264.7之抗發炎機制探討 | zh_TW |
dc.title | Anti-inflammatory effects of Solanum nigrum Linn leaf water extracts (SNE leaf) in murine macrophage RAW 264.7 | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 周綠蘋,何元順,陳彥州,蕭水銀 | |
dc.subject.keyword | 誘導型一氧化氮合成酶,第二型環氧合成酶,轉錄激活蛋白-1,核轉錄因子-κB,一氧化氮,促分裂素原活化蛋白激酶, | zh_TW |
dc.subject.keyword | iNOS,COX-2,AP-1,I-κB α,NF-κB,NO,MAPK, | en |
dc.relation.page | 69 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-06-17 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 2.46 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。